Sakar Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 17, 2025.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare has allotted 3,00,000 equity shares (face value Rs. 10 each) to four non-promoter allottees upon conversion of warrants issued on a preferential basis in December 2023. The company received Rs. 8.64 crore (Rs. 288 per share) as the balance 75% warrant exercise price. The original 5,00,000 warrants, issued at Rs. 384 each, have now been fully converted — 2,00,000 were converted in December 2024 and the remaining 3,00,000 in June 2025. The company's paid-up equity capital has increased to Rs. 22.25 crore, comprising 2,22,49,910 shares. The newly allotted shares are subject to SEBI lock-in rules and will rank equally with existing shares.
This is a routine completion of a previously announced preferential warrant issue — no fresh fundraising, as the money was committed in 2023. Shareholders may see minor dilution (under 1.5%), but all warrants are now converted, removing future dilution uncertainty from this instrument.